101 related articles for article (PubMed ID: 22760476)
1. The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block.
Anami A; Fukushima K; Takasaki Y; Sumida T; Waguri M; Wake N; Murashima A
Mod Rheumatol; 2013 Jul; 23(4):653-8. PubMed ID: 22760476
[TBL] [Abstract][Full Text] [Related]
2. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies.
Tsuboi H; Sumida T; Noma H; Yamagishi K; Anami A; Fukushima K; Horigome H; Maeno Y; Kishimoto M; Takasaki Y; Nakayama M; Waguri M; Sago H; Murashima A
Mod Rheumatol; 2016 Jul; 26(4):569-75. PubMed ID: 26457409
[TBL] [Abstract][Full Text] [Related]
3. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
[TBL] [Abstract][Full Text] [Related]
4. [Fetal complete heart block with myocarditis and maternal SS-A-/AA-B/antibodies].
Lang B; Wilhelm C; Gildein P; Vaith P; Schillinger H; Peter HH
Schweiz Med Wochenschr; 1990 Nov; 120(46):1741-4. PubMed ID: 2251494
[TBL] [Abstract][Full Text] [Related]
5. Relationship of maternal autoimmune response to clinical manifestations in children with congenital complete heart block.
Eronen M; Miettinen A; Walle TK; Chan EK; Julkunen H
Acta Paediatr; 2004 Jun; 93(6):803-9. PubMed ID: 15244231
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
[TBL] [Abstract][Full Text] [Related]
7. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of tests for SS-A/Ro, Ro52 and Ro60 in predicting congenital heart block].
Miyano A; Nakayama M; Waguri M; Nakanishi I
Rinsho Byori; 2014 Apr; 62(4):324-31. PubMed ID: 25022061
[TBL] [Abstract][Full Text] [Related]
10. Neonatal lupus erythematosus in Japan: a review of the literature.
Kobayashi R; Mii S; Nakano T; Harada H; Eto H
Autoimmun Rev; 2009 May; 8(6):462-6. PubMed ID: 19162245
[TBL] [Abstract][Full Text] [Related]
11. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
12. Anti-Ro (SS-A) antibodies and congenital complete heart block.
McNeil P; Edmonds J
Aust N Z J Med; 1985 Dec; 15(6):767-8. PubMed ID: 3914881
[TBL] [Abstract][Full Text] [Related]
13. Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus.
Ramsey-Goldman R; Hom D; Deng JS; Ziegler GC; Kahl LE; Steen VD; LaPorte RE; Medsger TA
Arthritis Rheum; 1986 Oct; 29(10):1269-73. PubMed ID: 3490264
[TBL] [Abstract][Full Text] [Related]
14. Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin--a role in the pathogenesis of congenital heart block?
Li JM; Horsfall AC; Maini RN
Clin Exp Immunol; 1995 Mar; 99(3):316-24. PubMed ID: 7882552
[TBL] [Abstract][Full Text] [Related]
15. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
[TBL] [Abstract][Full Text] [Related]
16. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of mothers of children with complete congenital heart block.
Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic plasmapheresis for the prevention of congenital complete heart block associated with anti-SS-A/Ro antibody and anti-SS-B/La antibody].
Miyakata S; Takeuchi K; Yamaji K; Kanai Y; Tsuda H; Takasaki Y
Ryumachi; 2001 Aug; 41(4):726-35. PubMed ID: 11577401
[TBL] [Abstract][Full Text] [Related]
19. [Neonatal lupus syndrome: Literature review].
Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block.
Taylor PV; Taylor KF; Norman A; Griffiths S; Scott JS
Br J Rheumatol; 1988 Apr; 27(2):128-32. PubMed ID: 3284603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
